Overview

Spinomix develops instruments and reagents enabling the manipulation and detection of biochemical substances using innovative technological MagPhase platform. This technology platform allows the integration of complex bio-molecules assays functionalities within a compact and easy to use system. Steps such as simple preparation, signal amplification and detection of multi-analytes are implemented into a single fast and reliable system.   

As particles assaying based technology, the MagPhase platform allows the integration of well established and widely adopted assaying protocols. The MagPie™ system is designed therefore as a versatile and open platform on which gradually different bio-assays will be implemented for diagnostics product development on a collaborative basis with strategic partners and global players.

The MagPhase platform's functionality, nucleic acid and protein sample preparation and detection in one instrument make it broadly applicable in numerous segments of the life sciences industry. The company currently has feasibility assessments and development efforts ongoing for key market opportunities.